Quick Answer
GT Biopharma, Inc. reported Shares Outstanding of 25.53 million shares for fiscal year 2025.
GT Biopharma, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 25.53M | +1042.8% |
| 2024 | 2.23M | +61.8% |
| 2023 | 1.38M | +26.6% |
| 2022 | 1.09M | -96.6% |
| 2021 | 32.06M | +514.4% |
| 2020 | 5.22M | +27.1% |
| 2019 | 4.10M | -91.9% |
| 2018 | 50.65M | +1.1% |
| 2017 | 50.12M | +47989.6% |
| 2016 | 104,218 | -95.7% |
| 2015 | 2.40M | +1.4% |
| 2014 | 2.37M | -99.6% |
| 2013 | 573.05M | +14.5% |
| 2012 | 500.57M | +85.9% |
| 2011 | 269.30M | +80.0% |
| 2010 | 149.57M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 6.05M | +170.9% | +84.9% |
| June 30, 2025 | 3.27M | +46.5% | +29.0% |
| March 31, 2025 | 2.54M | +83.7% | +13.5% |
| December 31, 2024 | 2.23M | +61.8% | +0.0% |
| September 30, 2024 | 2.23M | -94.6% | +0.0% |
| June 30, 2024 | 2.23M | -94.5% | +61.8% |
| March 31, 2024 | 1.38M | -96.3% | +0.0% |
| December 31, 2023 | 1.38M | -95.8% | -96.7% |
- GT Biopharma, Inc. showed an increase of +1042.8% in Shares Outstanding compared to the prior fiscal year.
- Over the 2010–2025 period, GT Biopharma, Inc.’s shares outstanding has declined by 82.9% (from 149.57 million shares to 25.53 million shares).
- The most recent figure is from GT Biopharma, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 2, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: